Tag: AstraZeneca

AstraZeneca advances mass global rollout of COVID-19 vaccine through COVAX

by The FINANCIAL

March 4, 2021

The FINANCIAL -- The first of many millions of doses of AstraZeneca’s COVID-19 vaccine have begun arriving in low and middle-income ...

AstraZeneca’s Calquence approved in the EU for the treatment of most common type of leukaemia in adults

by The FINANCIAL

November 9, 2020

The FINANCIAL -- AstraZeneca’s Calquence (acalabrutinib), a next-generation selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in the European Union ...

FDA approved AstraZeneca’s Brilinta to reduce the risk of stroke

by The FINANCIAL

November 6, 2020

The FINANCIAL -- AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of stroke, a leading cause of disability ...

EU approved AstraZeneca’s Forxiga for heart failure

by The FINANCIAL

November 5, 2020

The FINANCIAL -- AstraZeneca’s Forxiga (dapagliflozin) has been approved in the European Union (EU) for the treatment of symptomatic chronic heart failure ...

AstraZeneca to sell commercial rights to Atacand in more than 70 countries to Cheplapharm

by The FINANCIAL

October 30, 2020

The FINANCIAL -- AstraZeneca has agreed to sell the commercial rights to Atacand (candesartan cilexetil) and Atacand Plus (a fixed-dose combination of candesartan cilexetil ...

CHMP recommended approving Forxiga for heart failure treatment

by The FINANCIAL

October 19, 2020

The FINANCIAL -- AstraZeneca’s Forxiga (dapagliflozin) has been recommended for an indication extension of its marketing authorisation in the European Union (EU) ...

AstraZeneca’s Trixeo Aerosphere recommended for approval in the EU

by The FINANCIAL

October 19, 2020

The FINANCIAL -- AstraZeneca’s Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) has been recommended for marketing authorisation in the European Union (EU) for maintenance ...